登录

Shanghai Kindly Medical Instruments Raises $106 Million in Hong Kong IPO

作者: Mailman 2019-11-29 12:56
康德莱医疗器械
http://www.kdl-int.com
企业数据由 动脉橙 提供支持
医疗器械研发、生产及销售商 | IPO | 运营中
中国-上海
2019-11-08
融资金额:RMB¥5亿
查看

According to Global Legal Chronicle, Shanghai Kindly Medical Instruments Co., Ltd. ("Kindly Medical Instruments"), coded as "1501.HK", has raised HK$832 million (approximately US$106 million) on the Main Board of the Hong Kong Stock Exchange.


The Global Offering consists of a total number of 40,000,000 Offer Shares of the Company (before any exercise of the over-allotment option). This was an extraordinarily successful IPO, with its Hong Kong public shares oversubscribed by more than 260 times. In addition, there is an over-allotment option, for a total projected offering size of HK$957 million (US$122 million) should the over-allotment option be exercised in full.


Founded in 2006 in Jiading District, Shanghai, Kindly Medical Instruments has been focusing on the research and development, production and sales of interventional medical devices. The company is a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd (stock code: 603987.SH) which listed on the main board of the Shanghai Stock Exchange.


Kindly Medical Instruments is a leading Chinese cardiovascular interventional device manufacturer. It has designed, developed and produced cardiovascular intervention and other interventional medical devices in-house to meet different clinical needs. As of 19 October 2019, it had 62 registered patents, five registered software, 15 NMPA registration certificates for Class III medical devices, 12 Shanghai MPA registration certificates for Class II medical devices, 28 CE approved products and 10 FDA approved products.


BOCOM International (Asia) Ltd. is the Sole Sponsor. BOCOM International Securities Ltd. and CMB International Capital Ltd. are the Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers.


>>>>
About BOCOM International 


BOCOM International is a subsidiary of Bank of Communications Co., Ltd. It provides a wide range of financial services including securities brokerage, corporate finance, and asset management to our domestic and international clients.  


>>>>

About CMB international


CMB international is a comprehensive and professional financial institution based in Hong Kong. Relying on China Merchants Bank's strength and its social reputation, CMB International provides Hong Kong listing sponsor and underwriting, placement of listed companies and rights, financial advisory, bond issuance services, asset management, direct investment, wealth management, stock sales, and trading and other financial services.

相关赛道 其它耗材
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

流动性退潮倒计时?生物科技企业冲刺IPO

Hongyu Medical Closes on ¥30M Series A Round, Providing Interventional Treatment of Heart Disease in Pet Dogs

Shenzhi Technology Snags ¥10M in Series A, Focusing on Artificial Intelligence in Ultrasound

Singular Medical Bags over $10M in Series A Funding Round

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

FTC2019|章君琪:新价值医疗需要医生、公司、政府部门共同推动构建,其中医生是价值医疗的关键

2019-11-29
下一篇

德国基因疗法公司ViGeneron完成A轮融资,用于加速新型眼科基因疗法的研发

2019-11-29